| Kevin T Quang, DPM | |
|
5711 E 71st St Ste 115, Tulsa, OK 74136-6655 | |
| (918) 494-2955 | |
| (918) 494-2905 |
| Full Name | Kevin T Quang |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 8 Years |
| Location | 5711 E 71st St Ste 115, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376980193 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 319 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metro Tulsa Foot And Ankle Specialist Pllc | 1759293046 | 10 |
News Archive
NPR profiles retired General Eric Shinseki, the head of the Department of Veterans Affairs, and his efforts to measure the scope of veterans' mental health issues. In his first nine months in this position, he "has spent hours just listening to veterans talk. Shinseki tells NPR's Steve Inskeep that he feels a strong obligation to 'give back' to the men and women he once served with." NPR reports on the task Shinseki faces: "Since 2001, more than 1 million new veterans have come into a system that is being stretched thin." One of Shinseki's missions to improve the care and resources available to these vets is to work with the Department of Defense to "create a computer-driven system that will track service personnel through their careers — including when they become veterans.
Low-density lipoprotein cholesterol levels should be lowered as much as possible to prevent cardiovascular disease, especially in high and very high risk patients.
Cerus Corporation (NASDAQ:CERS) today announced that it has entered into definitive agreements with selected investors to sell 6,000,000 units, with each unit consisting of (i) one share of the Company's common stock and (ii) a warrant to purchase 0.4 of a share of the Company's common stock for gross proceeds of approximately $13.2 million in a "registered direct" offering.
Intrinsic Bioprobes today announced the exclusive licensing of two novel biomarkers for diabetes to Ortho-Clinical Diagnostics, Inc. (Raritan, NJ). The biomarkers are modified forms of blood-circulating proteins and have been linked with the presence of pre-diabetes and type 2 diabetes. The financial terms of the licensing agreement were not disclosed.
› Verified 2 days ago
| Provider Name | Metro Tulsa Foot & Ankle Specialist Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477588945 PECOS PAC ID: 1759293046 Enrollment ID: O20031104000660 |
News Archive
NPR profiles retired General Eric Shinseki, the head of the Department of Veterans Affairs, and his efforts to measure the scope of veterans' mental health issues. In his first nine months in this position, he "has spent hours just listening to veterans talk. Shinseki tells NPR's Steve Inskeep that he feels a strong obligation to 'give back' to the men and women he once served with." NPR reports on the task Shinseki faces: "Since 2001, more than 1 million new veterans have come into a system that is being stretched thin." One of Shinseki's missions to improve the care and resources available to these vets is to work with the Department of Defense to "create a computer-driven system that will track service personnel through their careers — including when they become veterans.
Low-density lipoprotein cholesterol levels should be lowered as much as possible to prevent cardiovascular disease, especially in high and very high risk patients.
Cerus Corporation (NASDAQ:CERS) today announced that it has entered into definitive agreements with selected investors to sell 6,000,000 units, with each unit consisting of (i) one share of the Company's common stock and (ii) a warrant to purchase 0.4 of a share of the Company's common stock for gross proceeds of approximately $13.2 million in a "registered direct" offering.
Intrinsic Bioprobes today announced the exclusive licensing of two novel biomarkers for diabetes to Ortho-Clinical Diagnostics, Inc. (Raritan, NJ). The biomarkers are modified forms of blood-circulating proteins and have been linked with the presence of pre-diabetes and type 2 diabetes. The financial terms of the licensing agreement were not disclosed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin T Quang, DPM 701 W. Elgin St, Broken Arrow, OK 74012 Ph: (918) 455-2001 | Kevin T Quang, DPM 5711 E 71st St Ste 115, Tulsa, OK 74136-6655 Ph: (918) 494-2955 |
News Archive
NPR profiles retired General Eric Shinseki, the head of the Department of Veterans Affairs, and his efforts to measure the scope of veterans' mental health issues. In his first nine months in this position, he "has spent hours just listening to veterans talk. Shinseki tells NPR's Steve Inskeep that he feels a strong obligation to 'give back' to the men and women he once served with." NPR reports on the task Shinseki faces: "Since 2001, more than 1 million new veterans have come into a system that is being stretched thin." One of Shinseki's missions to improve the care and resources available to these vets is to work with the Department of Defense to "create a computer-driven system that will track service personnel through their careers — including when they become veterans.
Low-density lipoprotein cholesterol levels should be lowered as much as possible to prevent cardiovascular disease, especially in high and very high risk patients.
Cerus Corporation (NASDAQ:CERS) today announced that it has entered into definitive agreements with selected investors to sell 6,000,000 units, with each unit consisting of (i) one share of the Company's common stock and (ii) a warrant to purchase 0.4 of a share of the Company's common stock for gross proceeds of approximately $13.2 million in a "registered direct" offering.
Intrinsic Bioprobes today announced the exclusive licensing of two novel biomarkers for diabetes to Ortho-Clinical Diagnostics, Inc. (Raritan, NJ). The biomarkers are modified forms of blood-circulating proteins and have been linked with the presence of pre-diabetes and type 2 diabetes. The financial terms of the licensing agreement were not disclosed.
› Verified 2 days ago
Dr. Abdurrahman Kabani, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6160 S Yale Ave, Tulsa, OK 74136 Phone: 918-499-4780 Fax: 918-499-4781 | |
Jeff Robert Finkenstaedt, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3540 East 31st, Suite 2, Tulsa, OK 74135 Phone: 918-747-8997 Fax: 918-744-8011 | |
Maureen Lee Crotty, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3627 S Harvard Ave, Tulsa, OK 74135 Phone: 918-494-2902 Fax: 918-494-2905 | |
Dr. Robert Hayes Lee, D.P.M. Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 3315 E 47th Pl, Suite 102, Tulsa, OK 74135 Phone: 918-749-4484 Fax: 918-749-2350 | |
David Alan Francis, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3627 S Harvard Ave, Tulsa, OK 74135 Phone: 918-747-4855 Fax: 918-747-4866 | |
Timothy B. Maclin Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4415 S Harvard Ave, Suite 101, Tulsa, OK 74135 Phone: 918-749-3228 Fax: 918-747-2759 | |
Mark C. Nahmias, Dpm, Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 5906 E 31st St, Suite 1, Tulsa, OK 74135 Phone: 918-749-9996 Fax: 918-622-9998 |